• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂酰肌醇3-激酶/蛋白激酶B通路在肺癌进展中的早期参与。

Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression.

作者信息

Massion Pierre P, Taflan Peter M, Shyr Yu, Rahman S M Jamshedur, Yildiz Pinar, Shakthour Bashar, Edgerton Mary E, Ninan Matthew, Andersen Jeremiah J, Gonzalez Adriana L

机构信息

Department of Medicine, Biostatistics Shared Resource, the Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232-6838, USA.

出版信息

Am J Respir Crit Care Med. 2004 Nov 15;170(10):1088-94. doi: 10.1164/rccm.200404-487OC. Epub 2004 Aug 18.

DOI:10.1164/rccm.200404-487OC
PMID:15317667
Abstract

Signaling through the phosphatidylinositol 3-kinase (PI3-kinase) pathway has been associated with lung tumorigenesis. We examined the association between gene copy number of the PI3-kinase catalytic subunit alpha (PIK3CA) and phosphorylated Akt expression in invasive and preinvasive lung cancers. We sought to determine at what stage of tumor development gene copy number increase or phosphorylated Akt overexpression might affect tumor development. We assessed PIK3CA gene copy number by fluorescence in situ hybridization and expression of phosphorylated Akt by immunohistochemistry in 242 invasive and 43 preinvasive lung cancers and correlated our findings with clinical outcome. The PIK3CA was amplified in 70% of squamous carcinomas, 38% of large cell carcinomas, 19% of adenocarcinomas, and 67% of small cell lung cancers. Phosphorylated Akt overexpression was frequently observed, and strongly so in 12 to 17% of lung cancers depending on nuclear or cytoplasmic localization. Neither PIK3CA gene copy number nor phosphorylated Akt protein expression had prognostic significance. In preinvasive lesions, amplification of the PIK3CA and overexpression of phosphorylated Akt were associated with severe dysplasia and each other. These observations suggest frequent and early involvement of the PI3-kinase pathway in lung cancer.

摘要

通过磷脂酰肌醇3激酶(PI3激酶)途径的信号传导与肺癌发生有关。我们研究了PI3激酶催化亚基α(PIK3CA)的基因拷贝数与浸润性和浸润前肺癌中磷酸化Akt表达之间的关联。我们试图确定在肿瘤发展的哪个阶段基因拷贝数增加或磷酸化Akt过表达可能影响肿瘤发展。我们通过荧光原位杂交评估PIK3CA基因拷贝数,并通过免疫组织化学评估242例浸润性肺癌和43例浸润前肺癌中磷酸化Akt的表达,并将我们的发现与临床结果相关联。PIK3CA在70%的鳞状细胞癌、38%的大细胞癌、19%的腺癌和67%的小细胞肺癌中扩增。经常观察到磷酸化Akt过表达,根据核或细胞质定位,在12%至17%的肺癌中过表达强烈。PIK3CA基因拷贝数和磷酸化Akt蛋白表达均无预后意义。在浸润前病变中,PIK3CA的扩增和磷酸化Akt的过表达与重度发育异常相关,且二者也相互关联。这些观察结果表明PI3激酶途径在肺癌中频繁且早期参与。

相似文献

1
Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression.磷脂酰肌醇3-激酶/蛋白激酶B通路在肺癌进展中的早期参与。
Am J Respir Crit Care Med. 2004 Nov 15;170(10):1088-94. doi: 10.1164/rccm.200404-487OC. Epub 2004 Aug 18.
2
A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.全面的免疫组化和分子方法研究膀胱尿路上皮癌中的 PI3K/AKT/mTOR(磷酸肌醇 3-激酶/v-akt 鼠胸腺瘤病毒致癌基因/雷帕霉素的哺乳动物靶标)通路。
BJU Int. 2012 Dec;110(11 Pt C):E1237-48. doi: 10.1111/j.1464-410X.2012.11569.x. Epub 2012 Oct 29.
3
Significance of p63 amplification and overexpression in lung cancer development and prognosis.p63扩增及过表达在肺癌发生发展及预后中的意义
Cancer Res. 2003 Nov 1;63(21):7113-21.
4
Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.非小细胞肺癌中表皮生长因子受体的蛋白过表达和基因扩增。一项免疫组织化学和荧光原位杂交研究。
Cancer. 2005 Mar 15;103(6):1265-73. doi: 10.1002/cncr.20909.
5
Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中PIK3CA和Akt/蛋白激酶B的分析
Oncol Rep. 2007 Jul;18(1):253-9.
6
Molecular alterations in AKT and its protein activation in human lung carcinomas.人类肺癌中 AKT 及其蛋白激活的分子改变。
Hum Pathol. 2012 Dec;43(12):2229-40. doi: 10.1016/j.humpath.2012.03.015. Epub 2012 Jun 28.
7
Phosphatidylinositol 3-kinase could be a promising target in lung cancer therapy.
J BUON. 2012 Oct-Dec;17(4):729-34.
8
Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.早期浸润性乳腺癌中磷酸化 Akt 表达的临床病理及分子意义。
Breast Cancer Res Treat. 2011 Jun;127(2):407-16. doi: 10.1007/s10549-010-1012-y. Epub 2010 Jul 9.
9
Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions.非小细胞肺癌和癌前支气管病变中AKT的频繁激活。
Carcinogenesis. 2004 Nov;25(11):2053-9. doi: 10.1093/carcin/bgh226. Epub 2004 Jul 7.
10
High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.中东患者结直肠癌中脂肪酸合酶表达的高患病率及其作为治疗靶点的潜在作用。
Am J Gastroenterol. 2009 Jul;104(7):1790-801. doi: 10.1038/ajg.2009.230. Epub 2009 Jun 2.

引用本文的文献

1
Ruthenium biochanin-A complex ameliorates lung carcinoma through the downregulation of the TGF-β/PPARγ/PI3K/TNF-α pathway in association with caspase-3-mediated apoptosis.钌-生物chanin-A复合物通过下调TGF-β/PPARγ/PI3K/TNF-α信号通路并联合caspase-3介导的凋亡来改善肺癌。
Toxicol Res. 2023 Apr 15;39(3):455-475. doi: 10.1007/s43188-023-00177-1. eCollection 2023 Jul.
2
Chronic obstructive pulmonary disease alters the genetic landscape and tumor immune microenvironment in lung cancer patients.慢性阻塞性肺疾病改变肺癌患者的基因图谱和肿瘤免疫微环境。
Front Oncol. 2023 Jun 14;13:1169874. doi: 10.3389/fonc.2023.1169874. eCollection 2023.
3
AT7867 Inhibits the Growth of Colorectal Cancer Stem-Like Cells and Stemness by Regulating the Stem Cell Maintenance Factor Ascl2 and Akt Signaling.
AT7867通过调节干细胞维持因子Ascl2和Akt信号通路抑制结直肠癌干细胞样细胞的生长和干性。
Stem Cells Int. 2023 Feb 14;2023:4199052. doi: 10.1155/2023/4199052. eCollection 2023.
4
Phase II Study of Taselisib in -Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.Taselisib 在非乳腺癌和非鳞状肺癌的 - 突变实体瘤中的 II 期研究:来自 NCI-MATCH ECOG-ACRIN 试验(EAY131)子协议 I 的结果。
JCO Precis Oncol. 2022 Feb;6:e2100424. doi: 10.1200/PO.21.00424.
5
Pongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells.蓬戈尔甲醚抑制肺癌细胞中的Akt并抑制癌症干细胞表型。
Pharmaceuticals (Basel). 2021 Oct 26;14(11):1085. doi: 10.3390/ph14111085.
6
Relevance of STK11 Mutations Regarding Immune Cell Infiltration, Drug Sensitivity, and Cellular Processes in Lung Adenocarcinoma.STK11突变与肺腺癌中免疫细胞浸润、药物敏感性及细胞过程的相关性
Front Oncol. 2020 Dec 23;10:580027. doi: 10.3389/fonc.2020.580027. eCollection 2020.
7
PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis.实体恶性肿瘤中的PIK3CA基因突变:与临床病理参数及预后的关联
Cancers (Basel). 2019 Dec 30;12(1):93. doi: 10.3390/cancers12010093.
8
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).SWOG S1400B(NCT02785913),一项评估 GDC-0032(Taselisib)治疗既往接受过治疗的 PI3K 阳性的 IV 期鳞状非小细胞肺癌(Lung-MAP 子研究)患者的 II 期研究。
J Thorac Oncol. 2019 Oct;14(10):1839-1846. doi: 10.1016/j.jtho.2019.05.029. Epub 2019 May 31.
9
Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.唾液腺癌中频繁的 PTEN 缺失和差异的 HER2/PI3K 信号通路改变:对靶向治疗的影响。
Cancer. 2018 Sep 15;124(18):3693-3705. doi: 10.1002/cncr.31600. Epub 2018 Oct 5.
10
SOX2 Drives Bronchial Dysplasia in a Novel Organotypic Model of Early Human Squamous Lung Cancer.SOX2在早期人类肺鳞状细胞癌新型器官型模型中驱动支气管发育异常。
Am J Respir Crit Care Med. 2017 Jun 1;195(11):1494-1508. doi: 10.1164/rccm.201510-2084OC.